Latest Infratil News

Page 1 of 2
Infratil has raised FY27 earnings guidance as data-centre demand accelerates across CDC and Longroad, with AI infrastructure now representing 73% of its NZ$22 billion asset base. The company is also sharpening its strategy around scaled growth platforms, contracted cash flows and selective new investments.
Nora Hopper
Nora Hopper
16 Sept 2026
Kingfish’s adjusted NAV rose 1.2% in August, broadly matching the NZX benchmark as Vista, Fisher & Paykel Healthcare and Delegat delivered the strongest portfolio gains. The fund still trades at a 7.5% discount to NAV, while its one-year shareholder return remains negative.
Claire Turing
Claire Turing
11 Sept 2026
Kingfish's August 2026 update reveals a solid start to FY2027 with standout profit growth from Mainfreight and a significant valuation rise for Infratil's CDC Data Centres.
Victor Sage
Victor Sage
17 Aug 2026
Kingfish Limited posted a net loss of NZD 13.6 million for FY2026, underperforming the NZX50 benchmark, but showed early signs of recovery in FY2027. The company re-elected two directors and maintained its focus on quality growth stocks amid a cautious economic outlook.
Victor Sage
Victor Sage
7 Aug 2026
Kingfish Limited outperformed the S&P/NZX50G with an 8.7% gross portfolio return in Q2 2026, driven by strong results from Fisher & Paykel Healthcare, Vista Group, and Infratil, while a2 Milk faced supply chain and regulatory challenges.
Victor Sage
Victor Sage
20 July 2026
CDC’s independent valuation jumped 23.6% to a mid-point of A$18.5 billion, propelled by contracted capacity exceeding 1GW and a major pipeline expansion to 3.9GW. Infratil’s nearly 50% stake now values at over A$9.2 billion.
Nora Hopper
Nora Hopper
6 July 2026
Infratil Limited has issued nearly 2.8 million new ordinary shares under its Dividend Reinvestment Plan at an issue price of NZD 14.70 each, expanding its capital base without altering shareholder rank.
Claire Turing
Claire Turing
29 June 2026
Kingfish Limited posted a $13.6 million net loss for the year ended 31 March 2026, with portfolio returns lagging the benchmark amid geopolitical tensions and AI sector uncertainty.
Victor Sage
Victor Sage
24 June 2026
Kingfish Limited's May update reveals a robust 5.5% portfolio return, driven by standout performances from Fisher & Paykel Healthcare and Infratil amid mixed sector headwinds.
Victor Sage
Victor Sage
12 June 2026
Infratil posted an 11% rise in operational EBITDAF to NZ$989 million in FY26, fuelled by a record 555MW CDC data centre contract and a 170% EBITDAF jump at Longroad Energy. The company refined its portfolio with over NZ$600 million in divestments and secured a BBB+ credit rating, underpinning a strong FY27 outlook.
Nora Hopper
Nora Hopper
26 May 2026
Infratil Investments has inked a deal with Macquarie Securities to offload 53.5 million Contact Energy shares at NZ$9.25 each, trimming its stake slightly and unlocking nearly half a billion NZD.
Maxwell Dee
Maxwell Dee
20 May 2026
Kingfish Limited’s portfolio edged higher in April, buoyed by strong performances from Mercury and Infratil, while a2 Milk and Summerset weighed on returns amid operational and economic headwinds.
Victor Sage
Victor Sage
13 May 2026

Browse the archive

Full archive